Women’s Health Market By Product Type (Oral Contraceptives, Prenatal Vitamins, Hormone Replacement Therapy, Pregnancy Test Kits, Fertility Monitors and Ovulation Kits, Breast Health Supplements, Vaginal Health Products, Other), By Application (Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, Polycystic Ovary Syndrome (PCOS), Menopause, Other), By Age (Adolescent Women (13-18 years), Young Adult Women (19-35 years), Middle-aged Women (36-50 years), Older Women (50+ years)), By Distribution Channel (Hospitals and Clinics, Pharmacies and Drugstores, Online Platforms, Specialty Stores), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Nov 2024 | Report ID: MI1429 | 235 Pages
Industry Outlook
The Women’s Health market accounted for USD 49.7 Billion in 2024 and is expected to reach USD 87.7 Billion by 2035, growing at a CAGR of around 5.3% between 2025 and 2035. The women's health market refers to products, services, and treatments, which target different needs of women at one or another period of their lives. These include reproductive, hormonal, menopausal, fertility, contraceptive, breast health, and mental health. The segments that constitute the market include drugs and pharmacies, medical equipment, healthy products and services, and services to manage both male and female health.
Market growth and advancement remain notable globally due to increased awareness and demands for services that support the health and healthcare needs of women along with continued improvement in the healthcare technologies.
Report Scope:
Parameter | Details |
---|---|
Largest Market | North America |
Fastest Growing Market | Asia Pacific |
Base Year | 2024 |
Market Size in 2024 | USD 49.7 Billion |
CAGR (2025-2035) | 5.3% |
Forecast Years | 2025-2035 |
Historical Data | 2018-2024 |
Market Size in 2035 | USD 87.7 Billion |
Countries Covered | U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, Switzerland, Sweden, Finland, Netherlands, Poland, Russia, China, India, Australia, Japan, South Korea, Singapore, Indonesia, Malaysia, Philippines, Brazil, Argentina, GCC Countries, and South Africa |
What We Cover | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PESTLE analysis, value chain analysis, regulatory landscape, pricing analysis by segments and region, company market share analysis, and 10 companies with scope for including additional 15 companies upon request |
Segments Covered | Product Type, Application, Age, Distribution Channel and Region |
To explore in-depth analysis in this report - Request Free Sample Report
Market Dynamics
Increasing Awareness of Women’s Health Issues Globally, Leading to Better Education
Rising awareness of women's health is a key trend in the market. In recent decades, there has been a marked change in how female health is spoken and acted upon in society. Campaigns and health systems have also helped contribute knowledge on disorders early in life, mostly cancer, reproductive wellness, mental wellness, and menopausal symptoms. Such awareness is making women approach the doctors' window earlier with symptoms they consider very normal and should be treated earlier.
According to the World Health Organization (WHO), over 70% of women in high-income countries are aware of health issues such as breast cancer and cervical screening. Thus, prevention, early detection, or a healthier lifestyle are becoming more popular. Also, awareness campaigns are making changes to the policies and encouraging more attention to the R&D of products and services for women's health. Education about the health of women also contributes to the penetration of stigmatized topics and the free discussion of topics like menstruation or sexual health.
Rising Prevalence of Chronic Diseases in Women, Driving Demand for Treatments
Women have more cases of chronic illnesses that are progressing steadily, and this puts them in need of more specialized healthcare treatments. More acute diseases such as cardiovascular diseases, diabetes, autoimmune diseases, and mental disorders diseases are being felt by women of this generation as compared to previous generations at this age. According to the American Heart Association (AHA), cardiovascular disease is the leading cause of death among women, accounting for nearly 1 in 3 female deaths globally.
These elevations are due to predispositions like aging citizens, including the effects of dieting and decreased physical activity in people. There is therefore a growing call for durable coping and management strategies, and these include pharmacological therapies and psychological and behavioral changes. Several chronic diseases have become common also, and the need for diagnosis, treatment, and constant care enhances the quality of life. This has shifted the styles of the health care service provision and delivery with more women demanding health plans and treatment that only they deserve.
High Cost of Healthcare Services and Treatments, Limiting Affordability for Many Women
The high cost of health care services and treatments remains too high for many women, especially those from low-income and rural backgrounds. While expensive healthcare solutions are available and rapidly increasing, the costs of such treatments as fertility care, Hormone Replacement Therapy, Chronic disease management, etc. may not be affordable to the intended broad market segment. This is compounded by increasing insurance costs as well as co-payments and out-of-pocket costs that lock out important care.
The existence of the healthcare gap is inevitable due to the inequality in healthcare costs for the underprivileged community. Thus, a lot of women are likely to delay or skip important therapies, which in turn likely to have negative impacts on their health. A number of these affordability issues can only be met through applied policies and innovations of better, yet cheaper health solutions.
Demand for Sustainable and Natural Health Products in the Women's Market
Consumer preferences for organic and environmentally friendly health products in the women's health niche are increasingly on the rise. Women are often more and more conscious of the dangers of synthetic chemicals and the consequent health risks and are eager to use organic, environmentally friendly, and cruelty-free products. Organic cosmetics, menstruation care products, and herb-based dietary supplements are proving appealing presently as people focus on the health and sustainability of the planet. Another reason for the emergence of this trend is the growing consumer expectations for more transparency of the company's ingredients and sustainability policies. More women are embracing healthy lifestyles making the natural and sustainable health products market a business opportunity that needs to be leveraged by brands.
Rising Interest in Preventive Health Solutions for Women’s Well-being
As more and more people are becoming conscious about their health, there are high chance that preventive healthcare products targeting women are in high demand. Routine checkups, early detection, and early treatment approaches, and early treatment efforts are becoming necessary since females are shifting their attention to preventive measures across their lifespans. This has led to an increase in mobile health applications for health applications, gadgets for tracking health, fitness programs, and nutrition advice, to minimize diseases such as heart disease, diabetes, and osteoporosis.
It is also important for many women to find non-pharmacological approaches to keeping hormones in check, dealing with stress and anxiety, as well as addressing many mental health issues through practicing yoga, maintaining correct nutrition, and engaging in mindful practices. This penchant for preventive solutions opens a massive market in the identification and provision of products and services that can prevent the manifestation of an ailment, encourage good practices, and the general maintenance of health.
Industry Experts Opinion
“According to our estimates, society benefits by $3 for every $1 spent on women's health. This is a very wise investment for society, not just for the health of women. Societies are healthy when women are healthy. It brings attention to how urgently women's health needs to be addressed. Additionally, it's drawing decision-makers' attention to the need to raise the standard of care that women are entitled to.”
- Dr Anita Zaidi, President of the Gender Equality Division at the Bill & Melinda Gates Foundation
“It would be like closing the door after the horse has run away to try to stop the diabetes epidemic by regulating adult lifestyles and utilizing biologics. Primordial and primary prevention in subsequent generations can only be aided by maintaining the health of adolescents and women during their reproductive years.”
- Chittaranjan S. Yajnik, director, diabetes unit, KEM Hospital, Pune
Segment Analysis
Based on the product type, the Women’s Health Market has been classified into Oral Contraceptives, Prenatal Vitamins, Hormone Replacement Therapy, Pregnancy Test Kits, Fertility Monitors and Ovulation Kits, Breast Health Supplements, and Vaginal Health Products. Pill and pregnancy test kits are common among other contraceptives in the reproductive health niche as they enable women to plan on when to conceive. Prenatal vitamins help the health of the pregnant woman while fertility charts and ovulation tests help women who are trying to conceive a child.
You can also buy individual sections of this report.
Would you like to review the price list for each section?
Hormone replacement therapy (HRT) is measured to have major roles in decreased menopause symptoms and avoidance of osteoporosis post-menopause. Furthermore, breast health supplements and vaginal health products are slowly finding their way into the market since so many women experience hormonal issues and vaginal dryness at some point in their life.
Based on the application, the Women’s Health Market has been classified into Hormonal Infertility, Postmenopausal Osteoporosis, Endometriosis, Contraception, Polycystic Ovary Syndrome (PCOS), Menopause, and others. Hormonal dysfunction and many diseases such as polycystic ovary syndrome (PCOS) are key drivers of fertility solutions, and osteoporosis in postmenopausal women require bone strengthening and hormonal regulation therapies.
The other trends worth mentioning are endometriosis and menopause which are rapidly emerging as significant issues for health care, with symptoms often only controllable by specialized services for women. More women are experiencing these conditions therefore the need for specific medical interventions increases. This segment also has other related concerns including mental wellbeing and sexual health which also fall under the new uptick of various health concerns inherent to women.
Regional Analysis
North America, especially the United States, is the largest market for women's health. This is attributed to strong healthcare facilities available, high healthcare expenditure, and a large populace sensitized to growing women's health concerns. The main players in the Contraceptive market in the United States are Johnson & Johnson and Pfizer which introduce meshes and devices for various purposes, starting from contraception up to menopause treatment.
Also, the need for reproductive health product innovations, fertility treatments, and new medical technologies therefore increases the market size. The increasing trend toward wellness and preventative care also drives this growth because women in this area are beginning to be more proactive about maintaining their health.
The Asia-Pacific region is the most rapidly growing women's health market with China, India, and Japan as key contributors to its growth. The increase in economic status, increase in the availability of health care facilities, and increase in consciousness level towards women's health leads to being responsible for this overall growth in this region. In countries such as Asian countries of India and China, there are increasing trends in fertility treatments, maternal health, and menopause care as the middle-class group population rises.
Furthermore, the increasing popularization of digital health solutions and wellness in the APAC countries offers fresh opportunities for such companies to offer unique health-related products. A relatively young population of the region, coupled with increased awareness of women's health solutions and a featured need for female-targeted healthcare products, is stimulating the growth of a large market for women's health.
Competitive Landscape
Competition in the women's health market is constantly evolving and the market share strategies introduced by companies are very extensive. Market leaders Johnson & Johnson and Bayer are interested in the further development of their portfolios, with a particular focus on medical repellants, contraception, and menopausal products. Pfizer and AbbVie are expanding their research and development to enable new hormone therapies and fertility treatments. Currently, manufacturers like Procter & Gamble are taking advantage of sustainability strategies and launching natural health products onto the market. Medtronic and Hologic are building their market share through acquisitions and advanced technology in diagnostics and technology in medical devices.
Telemedicine and AI integration by startups and digital health platforms have especially targeted the increasing need for personalized care solutions. This is especially so because further collaborations and partnerships between the pharmaceutical and the tech industries especially the Development of innovative solutions especially in Personalized women's health are also fueling the advancement in this field. Market leaders are also increasing efforts to penetrate more into new markets by coming up with products that tackle conditions that are prevalent in those areas.
Women’s Health Market, Company Shares Analysis, 2024
To explore in-depth analysis in this report - Request Free Sample Report
Recent Developments:
- In October 2024, Bayer became an industrial partner of the innovative, deep-tech start-up Impli in precision care. Impli was aimed to improve women's health and offer the possibility to create the first live hormone monitoring device – fertility became closer, safer, and more effective.
- In February 2024, Rosy Wellness, led by Dr. Lyndsey Harper, expanded its platform to cover broader aspects of women's health, adding new features targeting conditions such as endometriosis, menopause, fibroids, and migraines. This move reflects a significant expansion beyond sexual wellness.
Report Coverage:
By Product Type
- Oral Contraceptives
- Prenatal Vitamins
- Hormone Replacement Therapy
- Pregnancy Test Kits
- Fertility Monitors and Ovulation Kits
- Breast Health Supplements
- Vaginal Health Products
- Other
By Application
- Hormonal Infertility
- Postmenopausal Osteoporosis
- Endometriosis
- Contraception
- Polycystic Ovary Syndrome (PCOS)
- Menopause
- Other
By Age
- Adolescent Women (13-18 years)
- Young Adult Women (19-35 years)
- Middle-aged women (36-50 years)
- Older Women (50+ years)
Distribution Channel
- Hospitals and Clinics
- Pharmacies and Drugstores
- Online Platforms
- Specialty Stores
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Johnson & Johnson
- Bayer
- Pfizer Inc.
- Merck & Co., Inc.
- AbbVie Inc.
- Novo Nordisk
- GlaxoSmithKline
- Procter & Gamble
- Stryker Corporation
- Medtronic
- Viatris
- Hologic, Inc.
- Ferring Pharmaceuticals
- Organon & Co.
- Teva Pharmaceuticals
- Astellas Pharma
- Amgen Inc.
- Bristol-Myers Squibb
Frequently Asked Questions (FAQs)
The Women’s Health market accounted for USD 49.7 Billion in 2024 and is expected to reach USD 87.7 Billion by 2035, growing at a CAGR of around 5.3% between 2025 and 2035.
Key growth opportunities in the Women’s Health Market Demand Sustainable and Natural Health Products in Women's Market, Growth of Women's Health-focused Wellness Programs and Services, and Rising Interest in Preventive Health Solutions for Women's Well-being.
The largest segment in the women’s health market is reproductive health, encompassing contraception, fertility treatments, pregnancy care, and menopause management, driven by consistent demand for family planning and maternal health solutions. The fastest-growing segment is menopause care, fueled by an aging female population and increasing awareness, with rising demand for hormone replacement therapy and products to alleviate symptoms like hot flashes and bone loss.
The Asia-Pacific (APAC) region will significantly contribute to the global women's health market due to its rapidly growing population, improving healthcare infrastructure, and rising awareness of women's health issues. Countries like China and India are experiencing increasing demand for reproductive health services, fertility treatments, and menopause care, driving market growth in the region.
Leading global women's health market players include major pharmaceutical and healthcare companies such as Johnson & Johnson, Pfizer, Bayer, AbbVie, and Procter & Gamble. These companies dominate through their extensive portfolios of products for reproductive health, menopause care, fertility treatments, and wellness solutions, leveraging innovation, research, and global distribution networks to meet the growing demand for women's health products and services.
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.